According to FutureWise analysis, the market for IPV Vaccines is expected to grow with a CAGR of 8.5% over the forecast period 2024-2032, and reach a market value of US$ 0.36 billion by 2031.
IPV vaccine, also known as inactivated poliovirus vaccine, is a vaccine that protects against polio. The IPV contains killed poliovirus strains, so it cannot cause the disease. It stimulates the body's immune system to produce antibodies against the virus, providing immunity. It is given by injection into the muscle of the arm or leg. IPV is a safe and effective vaccine. It is very good at preventing polio and does not have a small risk of causing polio associated with the oral polio vaccine (OPV). IPV is also recommended for adults who have not been vaccinated against polio or are unsure of their vaccination status. The most common side effects are mild and go away on their own within a few days. These side effects may include soreness, redness, headache, swelling at the injection area, fatigue, and low-grade fever.
There are various brands of polio vaccines. Each vaccine plays a crucial role in the global effort to eliminate polio, a highly infectious viral disease that may lead to paralysis and even death. Poliovac (Pfs/Sd) is one of the vaccines in use, designed to protect individuals against the poliovirus. Similarly, shanipv, poliorix, ipol/imovax, and polymilex are also respected brands in the fight against polio. These vaccines work by boosting the body's immune system to recognize and defend against the poliovirus, thereby providing immunity to the disease. Efforts to combat polio involve extensive vaccination campaigns, especially in regions where the virus still poses a threat. These vaccines are administered through various methods, including oral drops and injections, tailored to suit different age groups and population demographics.
FutureWise Market Research has published a report that provides an insightful analysis IPV vaccines market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts IPV vaccines market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.